Literature DB >> 19700213

Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose.

Marco van Vulpen1, Cornelis A T van den Berg, Maaike R Moman, Uulke A van der Heide.   

Abstract

In the previous decades the distinction between a local relapse and distant metastases was difficult to accomplish in an early stage. As a consequence, a failure could only be coarsely related to the original radiotherapy treatment. Currently, due to better imaging and position verification techniques, the actual dose within the prostate can be estimated, taking position uncertainties into account. Furthermore, advanced functional MRI techniques, such as MR spectroscopy (MRS) and dynamic contrast-enhanced MRI (DCE-MRI), increase the chance of localizing a local recurrence within the prostate. With this information the correlation between the actual previously delivered dose and a local relapse can be established, using non-rigid registration of the planning CT and the post-recurrence MRI. The current study describes the possibilities and problems in obtaining this correlation. This serves as a framework for investigating a reliable dose effect relationship in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19700213     DOI: 10.1016/j.radonc.2009.06.033

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

Review 1.  Functional MRI for radiotherapy dose painting.

Authors:  Uulke A van der Heide; Antonetta C Houweling; Greetje Groenendaal; Regina G H Beets-Tan; Philippe Lambin
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy.

Authors:  Gilles Crehange; Devan Krishnamurthy; J Adam Cunha; Barby Pickett; John Kurhanewicz; I-Chow Hsu; Alexander R Gottschalk; Katsuto Shinohara; Mack Roach; Jean Pouliot
Journal:  Radiother Oncol       Date:  2013-11-11       Impact factor: 6.280

Review 3.  [Treatment planning with functional MRI].

Authors:  P Georg; P Andrzejewski; K Pinker; D Georg
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

4.  Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.

Authors:  Irene M Lips; Uulke A van der Heide; Karin Haustermans; Emile N J T van Lin; Floris Pos; Stefan P G Franken; Alexis N T J Kotte; Carla H van Gils; Marco van Vulpen
Journal:  Trials       Date:  2011-12-05       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.